B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 700 KRW 1.99% Market Closed
Market Cap: 433.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

Operating Margin
BioPlus Co Ltd

30.2%
Current
43%
Average
4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
30.2%
=
Operating Profit
16.1B
/
Revenue
53.5B

Operating Margin Across Competitors

Country KR
Market Cap 433.5B KRW
Operating Margin
30%
Country JP
Market Cap 6.9T JPY
Operating Margin
28%
Country CH
Market Cap 37.7B CHF
Operating Margin
13%
Country DK
Market Cap 179.1B DKK
Operating Margin
27%
Country US
Market Cap 15.8B USD
Operating Margin
17%
Country CN
Market Cap 52B CNY
Operating Margin
45%
Country CA
Market Cap 6.3B USD
Operating Margin
4%
Country KR
Market Cap 9.1T KRW
Operating Margin
-245%
Country US
Market Cap 6.2B USD
Operating Margin
32%
Country US
Market Cap 5.7B USD
Operating Margin
12%
Country UK
Market Cap 4.5B GBP
Operating Margin
13%
No Stocks Found

BioPlus Co Ltd
Glance View

Market Cap
433.5B KRW
Industry
Health Care

BioPlus Co., Ltd. is engaged in the manufacturing and supplying of diverse dermal fillers. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2021-09-27. The firm is engaged in the production and sale of biomaterials for tissue restoration used for temporary improvement of facial wrinkles, namely hyaluronic acid fillers. In addition, the Company is engaged in the production and sale of anti-adhesion agents that reduce the formation of adhesions in surgical areas, biomaterials for joint tissue repair, and other products.

Intrinsic Value
15 791.58 KRW
Undervaluation 51%
Intrinsic Value
Price
B

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
30.2%
=
Operating Profit
16.1B
/
Revenue
53.5B
What is the Operating Margin of BioPlus Co Ltd?

Based on BioPlus Co Ltd's most recent financial statements, the company has Operating Margin of 30.2%.